AQX.L vs. NVO

Last updated Jun 5, 2026

AQX.L (Aquis Exchange plc) and NVO (Novo Nordisk A/S) are both stocks. AQX.L operates in Financial Data & Stock Exchanges (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). At a 0.03 correlation, their price movements are largely independent.

Performance

AQX.L vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Aquis Exchange plc (AQX.L) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

AQX.L is traded in GBp, while NVO is traded in USD. To make them comparable, the NVO values have been converted to GBp using the latest available exchange rates.

Returns By Period

AQX.L

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NVO

• 1D: 4.17%
• 1M: -1.60%
• YTD: -10.65%
• 6M: -6.30%
• 1Y: -35.82%
• 3Y*: -17.83%
• 5Y*: 4.86%
• 10Y*: 7.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

AQX.L vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
AQX.L Aquis Exchange plc	0.00%	-100.00%	91.10%	-3.95%	-39.68%	34.04%	16.92%	-29.78%	54.73%
NVO Novo Nordisk A/S	-10.65%	-43.55%	-14.46%	47.10%	37.24%	65.07%	19.71%	23.81%	7.27%

Correlation

The correlation between AQX.L and NVO is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.05
Correlation (5Y) Calculated over the trailing 5-year period	0.03
Correlation (All Time) Calculated using the full available price history since Jun 15, 2018	0.03

Fundamentals

Total Revenue (TTM) AQX.L : £47.48M NVO : $327.80B
Gross Profit (TTM) AQX.L : £15.81M NVO : $268.30B
EBITDA (TTM) AQX.L : £8.52M NVO : $181.54B

Return for Risk

AQX.L vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO

NVO Risk / Return Rank: 16
NVO Sharpe Ratio Rank: 12
NVO Sortino Ratio Rank: 15
NVO Omega Ratio Rank: 13
NVO Calmar Ratio Rank: 18
NVO Martin Ratio Rank: 22

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AQX.L vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aquis Exchange plc (AQX.L) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	AQX.L	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.71	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.13	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.23	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.52	—

Drawdowns

Drawdown Indicators

	AQX.L	NVO	Difference
Max Drawdown Largest peak-to-trough decline	—	-75.79%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-53.82%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-75.79%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-75.79%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-75.79%	—
Current Drawdown Current decline from peak	—	-69.95%	—
Average Drawdown Average peak-to-trough decline	—	-11.89%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	36.17%	—

Volatility

Volatility by Period

	AQX.L	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	8.55%	—
Volatility (6M) Calculated over the trailing 6-month period	—	37.06%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	50.82%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	37.86%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	32.61%	—

Dividends

AQX.L vs. NVO - Dividend Comparison

AQX.L has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.12%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AQX.L Aquis Exchange plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	4.12%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Financials

Frequently Asked Questions

Can I hold both AQX.L and NVO in my portfolio?

AQX.L and NVO have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.